Overview Artificial intelligence seems to be transforming drug discovery in 2026, enabling faster molecule design, smarter clinical trials, and reduced R&D ...

Ethereum co-founder Vitalik Buterin laid out a quantum resistance roadmap targeting four key vulnerabilities in the network’s cryptography.

Titled “The 2028 Global Intelligence Crisis,” the viral essay by Citrini Research and Alap Shah paints a catastrophic picture ...

Vitalik maps out quantum risks as Ethereum Strawmap outlines seven forks to strengthen post-quantum security, scalability, and finality.

Excessive social media use fragments attention, promotes shallow thinking, reinforces echo chambers, and weakens memory and ...

On January 29, Chinese developer Qu Jiangfeng was using Antigravity AI, a product of Google DeepMind, to clean up project ...

Vitalik Buterin proposed what he called a quantum roadmap on Thursday. He wants to update the cryptography that secures the blockchain. At least one change could make its way into an Ethereum upgrade ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

Those that solve artificially simplified problems where quantum advantage is meaningless. Those that provide no genuine quantum advantage when all costs are properly accounted for. This critique is ...

Former NYDIG and Two Sigma executives are building Five Bells Settlement to tackle counterparty risk in digital assets ...

Oracle-based quantum algorithms cannot use deep loops because quantum states exist only as mathematical amplitudes in Hilbert space with no physical substrate. Criticall ...